Five Prime surges after reporting results of cancer treatment trial Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Five Prime (FPRX) up 287% after announcing topline results from the Phase 2 FIGHT trial of bemarituzumab in gastric/gastroesophageal junction cancer patients
- Surface Oncology (SURF) up 9% after
announcing that that the FDA has granted Fast Track designation to SRF388 for the treatment of patients with hepatocellular carcinoma, or liver cancer, who have been previously treated with standard therapies
UP AFTER EARNINGS -
- Lemonade (LMND) up 1%
- Huya (HUYA) up 4%
- FuboTV (FUBO) up 24%
- Lyft (LYFT) up 5%
DOWN AFTER EARNINGS -
- Air Products (APD) down 4%
- eGain (EGAN) down 23%
- Datadog (DDOG) down 7%
ALSO LOWER -
- Aurora Cannabis (ACB) down 18% after announcing a $125M unit offering
- BigCommerce (BIGC) down 3% after filing to sell 5M shares of Series 1 common stock
- Tilray (TLRY) down 5% after Stifel analyst Andrew Carter downgraded shares to Sell from Hold with a price target of $4.75, down from $6
- Arbor Realty (ABR) down 3% after 7M share spot secondary priced at $13.50
Symbols:
FPRX TLRY BIGC ACB DDOG EGAN APD LYFT FUBO HUYA LMND SURF ABR Keywords: Fly Intel, Wall Street, Top Stories, Stocks